SLC13A5 Antikörper (Center)
Kurzübersicht für SLC13A5 Antikörper (Center) (ABIN650937)
Target
Alle SLC13A5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 151-180, Center
-
Spezifität
- This S13A5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 158~188 amino acids from the Central region of human S13A5.
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This S13A5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 151-180 AA from the Central region of human S13A5.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB = 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Haltbarkeit
- 6 months
-
-
- SLC13A5 (Solute Carrier Family 13 Member 5 (SLC13A5))
-
Andere Bezeichnung
- S13A5
-
Hintergrund
-
S13A5 is a tricarboxylate plasma transporter with a preference for citrate.
Synonyms: Sodium-dependent citrate transporter, Sodium-coupled citrate transporter, Na(+)/citrate cotransporter, NaCT, Solute carrier family 13 member 5,NACT, SLC13A5 -
Molekulargewicht
- 63062 DA
-
Gen-ID
- 284111
-
UniProt
- Q86YT5
-
Pathways
- Dicarboxylic Acid Transport
Target
-